PhotoPharmics Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $26.2M

  • Investors
  • 12

PhotoPharmics General Information

Description

Developer of non-invasive therapies designed to improve the lives of patients suffering from neurological disorders and addictions. The company's therapies offer chrono-biological treatments for Parkinson's disease, and a medical edge-lit device used to treat neurological disorders, enabling medical institutions to restore the health of patients suffering from Parkinson's disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3450 North Triumph Boulevard
  • Suite 400
  • Lehi, UT 84043
  • United States
+1 (801)
Primary Industry
Other Devices and Supplies
Corporate Office
  • 3450 North Triumph Boulevard
  • Suite 400
  • Lehi, UT 84043
  • United States
+1 (801)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PhotoPharmics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series B) 03-Nov-2025 $26.2M Completed Clinical Trials - Phase 3
7. Grant 15-Jun-2021 Completed Clinical Trials - Phase 3
6. Later Stage VC (Series A) 11-Oct-2019 Completed Clinical Trials - Phase 2
5. Later Stage VC 27-Feb-2017 Completed Clinical Trials - Phase 2
4. Early Stage VC (Series 2) 19-Jun-2015 Completed Startup
3. Early Stage VC (Series A) 05-May-2015 Completed Startup
2. Seed Round 04-Jan-2013 $2.73M $2.73M Completed Startup
1. Seed Round 27-Dec-2012 Completed Startup
To view PhotoPharmics’s complete valuation and funding history, request access »

PhotoPharmics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-4
Series B-3
Series B-2
Series B-1
Series A 1,265,614 $0.000100 $5.25 $5.25 1x $4.31 11.51%
Seed 2,360,706 $0.000100 $2.21 $2.21 1x $2.21 17.62%
To view PhotoPharmics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

PhotoPharmics Patents

PhotoPharmics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2013180749-A1 Apparatuses for treating and/or diagnosing motor related neurological conditions Inactive 31-May-2012
AU-2012381077-A1 Apparatuses for treating and/or diagnosing motor-related neurological conditions Inactive 31-May-2012
AU-2017265164-A1 Apparatuses for treating and/or diagnosing motor-related neurological conditions Active 31-May-2012
AU-2017265164-B2 Apparatuses for treating and/or diagnosing motor-related neurological conditions Active 31-May-2012
CA-2874996-A1 Apparatuses for treating and/or diagnosing motor-related neurological conditions Active 31-May-2012 A61N5/0618
To view PhotoPharmics’s complete patent history, request access »

PhotoPharmics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PhotoPharmics Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel Star Ventures Angel Group Minority
FJ Management Holding Company Minority
Angel (individual) Minority
MedTech Innovator Accelerator/Incubator
PC Squared (Salt Lake City) Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

PhotoPharmics FAQs

  • When was PhotoPharmics founded?

    PhotoPharmics was founded in 2011.

  • Where is PhotoPharmics headquartered?

    PhotoPharmics is headquartered in Lehi, UT.

  • What is the size of PhotoPharmics?

    PhotoPharmics has 9 total employees.

  • What industry is PhotoPharmics in?

    PhotoPharmics’s primary industry is Other Devices and Supplies.

  • Is PhotoPharmics a private or public company?

    PhotoPharmics is a Private company.

  • What is the current valuation of PhotoPharmics?

    The current valuation of PhotoPharmics is .

  • What is PhotoPharmics’s current revenue?

    The current revenue for PhotoPharmics is .

  • How much funding has PhotoPharmics raised over time?

    PhotoPharmics has raised $50.9M.

  • Who are PhotoPharmics’s investors?

    Angel Star Ventures, FJ Management, , MedTech Innovator, and PC Squared (Salt Lake City) are 5 of 12 investors who have invested in PhotoPharmics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process